Get Mesa Verde Venture Partners contact and information in the United States

Investor Type	Firm
Type of Fund	Venture Capital Fund
Industries	BioTech • HealthTech (& Fitness)
Stages	Early, Seed, Series A, Series B
Investing	United States
Investment Range	$3,000,000 - $30,000,000

Who are the key investors at Mesa Verde Venture Partners?

What is Mesa Verde Venture Partners?

Mesa Verde Venture Partners is an early-stage life sciences venture capital firm established in 2006, with a focus on creating partnerships with entrepreneurs to build successful companies in the life sciences sector. Based in San Diego, California, Mesa Verde targets investment opportunities primarily in Southern California and the Southwest, as well as other regions that have traditionally been underrepresented in life sciences venture capital.

They have over 20 years of experience in the field and a record of over 20 life sciences investments. Their investment strategy emphasizes a diversified portfolio approach, with interests spanning pharmaceuticals, medical devices, diagnostics, life science enabling tools, and digital health.

Mesa Verde Venture Partners actively seeks companies that show promise in biotechnology, medical technology, drug discovery tools, healthcare information technology, and related sectors within the BioTech and HealthTech industries. With an investment range of $3 million to $30 million, they concentrate on early-stage companies that have the potential to lead in their respective niches and produce superior returns. The team at Mesa Verde includes three Managing Directors—Carey Ng, PhD, MBA; Fred Middleton, MBA; Francois Ferre, PhD—alongside seasoned Advisors and Partners who carry expertise in building and investing in burgeoning life science enterprises.

Their portfolio showcases a history of successful exits and public listings, demonstrating a track record of identifying and nurturing high-potential investments. They aim to be a cornerstone in the advancement of technologies that will improve human health.

Mesa Verde also shares updates on their portfolio companies' progress, highlighting significant business developments and financial results, showing their commitment to transparency and involvement in their investments' growth trajectories.

What they say:

We are a venture capital firm with a diversified portfolio.

What we look for: We invest in early-stage biotechnology and medical technology companies.

Mesa Verde Venture Partners's investments on record

Elevation Pharmaceuticals	$30,000,000.00	Series B
Exagen Diagnostics	$25,000,000.00	Debt Financing
Elevation Pharmaceuticals	$17,000,000.00	Series A
Lineagen	$16,000,000.00	Series B
Lineagen	$12,170,000.00	Series C
Paradigm Cancer Diagnostic	$7,400,000.00
Paradigm Diagnostics	$7,000,000.00	Series B
Exagen Diagnostics	$5,300,000.00	Private Equity Round
Lineagen	$3,500,000.00	Series C